Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

noretreat

Rank: Vice President [?]

Points: 1412 [?]

Votes: 14 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.

in response to

Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.

narmac

posted on Nov 17, 2021 05:33PM

Somebody still likes this pipeline

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply